Rethinking Regulatory Protections for Accelerated Approvals With Supplementary Indications
C
Catherine S. Hwang
(Division of General Internal Medicine and Geriatrics, Oregon Health and Science University, Portland, OR)
M
Martha S. Gerrity
(Division of General Internal Medicine and Geriatrics, Oregon Health and Science University, Portland, OR)
S
S. Sean Tu
(University of Alabama School of Law, Tuscaloosa)
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 1, Issue 1
Published
July 29, 2026
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (3)
C
Catherine S. Hwang
Division of General Internal Medicine and Geriatrics, Oregon Health and Science University, Portland, OR
M
Martha S. Gerrity
Division of General Internal Medicine and Geriatrics, Oregon Health and Science University, Portland, OR
S
S. Sean Tu
University of Alabama School of Law, Tuscaloosa
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001